Page last updated: 2024-08-23

substance p and Mood Disorders

substance p has been researched along with Mood Disorders in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19901 (8.33)18.7374
1990's1 (8.33)18.2507
2000's8 (66.67)29.6817
2010's2 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Heilig, M; Schank, JR1
Katsouni, E; Liapi, C; Sakkas, P; Skandali, N; Zarros, A1
Nakagawa, H; Yano, C1
Herpfer, I; Lieb, K1
Caberlotto, L; Carletti, R; Corsi, M; Melotto, S1
Matsubayashi, S; Matsumoto, S1
Czéh, B; Fuchs, E; Simon, M1
Ebner, K; Singewald, N1
Rosenkranz, MA1
Arinami, T; Hamaguchi, H; Itokawa, M; Li, L; Mitsushio, H; Toru, M1
Berger, M; Fiebich, BL; Lieb, K; Treffurth, Y1
Mataga, N; Mitsushio, H; Takashima, M; Toru, M1

Reviews

8 review(s) available for substance p and Mood Disorders

ArticleYear
Substance P and the Neurokinin-1 Receptor: The New CRF.
    International review of neurobiology, 2017, Volume: 136

    Topics: Animals; Humans; Mood Disorders; Neurokinin-1 Receptor Antagonists; Receptors, Neurokinin-1; Substance P; Substance-Related Disorders

2017
The involvement of substance P in the induction of aggressive behavior.
    Peptides, 2009, Volume: 30, Issue:8

    Topics: Aggression; Animals; Anxiety Disorders; Humans; Mood Disorders; Rage; Receptors, Neurokinin-1; Substance P

2009
Substance P and Substance P receptor antagonists in the pathogenesis and treatment of affective disorders.
    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2003, Volume: 4, Issue:2

    Topics: Animals; Antidepressive Agents; Humans; Mood Disorders; Neurokinin-1 Receptor Antagonists; Polymorphism, Genetic; Renin; Substance P

2003
[Substance P].
    Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63 Suppl 8

    Topics: Arthritis, Rheumatoid; Biomarkers; Diagnostic Techniques, Endocrine; Humans; Immunoenzyme Techniques; Mood Disorders; Pain; Reagent Kits, Diagnostic; Respiratory Tract Diseases; Shock, Septic; Specimen Handling; Substance P

2005
NK1 receptor antagonists under investigation for the treatment of affective disorders.
    Expert opinion on investigational drugs, 2006, Volume: 15, Issue:5

    Topics: Animals; Drugs, Investigational; Humans; Mood Disorders; Neurokinin-1 Receptor Antagonists; Receptors, Neurokinin-1; Substance P

2006
The role of substance P in stress and anxiety responses.
    Amino acids, 2006, Volume: 31, Issue:3

    Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Brain; Depression; Humans; Hypothalamo-Hypophyseal System; Mood Disorders; Neurokinin-1 Receptor Antagonists; Pituitary-Adrenal System; Psychotropic Drugs; Receptors, Neurokinin-1; Serotonin; Stress, Physiological; Substance P; Synaptic Transmission

2006
Substance P at the nexus of mind and body in chronic inflammation and affective disorders.
    Psychological bulletin, 2007, Volume: 133, Issue:6

    Topics: Adrenal Medulla; Asthma; Chronic Disease; Humans; Hypothalamo-Hypophyseal System; Inflammation; Mood Disorders; Pituitary-Adrenal System; Psychophysiology; Substance P

2007
Substance P and affective disorders: new treatment opportunities by neurokinin 1 receptor antagonists?
    Neuropsychobiology, 2002, Volume: 45 Suppl 1

    Topics: Animals; Bipolar Disorder; Humans; Mood Disorders; Neurokinin-1 Receptor Antagonists; Substance P

2002

Other Studies

4 other study(ies) available for substance p and Mood Disorders

ArticleYear
[Substance P].
    Nihon rinsho. Japanese journal of clinical medicine, 2010, Volume: 68 Suppl 7

    Topics: Dermatitis, Atopic; Humans; Immunoenzyme Techniques; Mood Disorders; Pain; Pneumonia, Aspiration; Substance P

2010
Down-regulation of amygdala preprotachykinin A mRNA but not 3H-SP receptor binding sites in subjects affected by mood disorders and schizophrenia.
    The European journal of neuroscience, 2005, Volume: 21, Issue:6

    Topics: Adult; Aged; Amygdala; Binding Sites; Down-Regulation; Female; Humans; Male; Middle Aged; Mood Disorders; Protein Precursors; RNA, Messenger; Schizophrenia; Substance P; Tachykinins; Tritium

2005
An insertion/deletion polymorphism in the angiotensin converting enzyme gene is associated with both brain substance P contents and affective disorders.
    Biological psychiatry, 1996, Dec-01, Volume: 40, Issue:11

    Topics: Adult; Aged; Alleles; Brain Chemistry; DNA Transposable Elements; Female; Genotype; Humans; Male; Middle Aged; Mood Disorders; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Schizophrenia; Sequence Deletion; Substance P

1996
Effects of chronic treatment with trihexyphenidyl and carbamazepine alone or in combination with haloperidol on substance P content in rat brain: a possible implication of substance P in affective disorders.
    The Journal of pharmacology and experimental therapeutics, 1988, Volume: 245, Issue:3

    Topics: Animals; Body Weight; Brain Chemistry; Carbamazepine; Dopamine; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Haloperidol; Lithium; Male; Mood Disorders; Rats; Rats, Inbred Strains; Serotonin; Substance P; Trihexyphenidyl

1988